Accepted for/Published in: JMIR Formative Research
Date Submitted: Apr 6, 2024
Date Accepted: Nov 6, 2024
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Quantifying the Regional Disproportionality of COVID-19 Spread
ABSTRACT
Background:
The COVID-19 pandemic has caused serious health problems and has had major economic and social consequences worldwide. Understanding how infectious diseases spread can help mitigating the social and economic impact.
Objective:
The study focuses to capture the degrees of disproportionality in prevalence rates of infectious disease across different regions over time.
Methods:
We analyze the numbers of daily COVID-19 confirmed cases in the United States collected by Johns Hopkins University over 1100 days since the first reported case in January 2020 in order to assess quantitatively the disproportionality of the confirmed cases using the Theil index, a measure of imbalance used in economics.
Results:
Our results reveal a dynamic pattern of interregional disproportionality in the confirmed cases by monitoring variations in regional contributions to the Theil index as the pandemic progresses.
Conclusions:
The combined monitoring of this indicator and the confirmed cases is crucial for understanding regional differences in infectious diseases and for effective planning of response and resource allocation.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.